Back
EHRA Premium Access

Patients in New York Heart Association functional class I might benefit from primary prevention implantable cardioverter defibrillator therapy

Session: Ventricular arrhythmias and sudden cardiac death (clinical aspects)
Topic: Device Treatment of Ventricular Arrhythmias and SCD
Speaker: Miss A. van der Lingen (Amsterdam, NL)
Event: EHRA 2018

Congress Presentation

About the speaker

Miss Anne-Lotte van der Lingen

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))
0 follower

7 more presentations in this session

First degree atrioventricular block on basal electrocardiogram predicts future arrhythmic events in patients with brugada syndrome

Speaker: Doctor M. Testolina (Padua, IT)

Access
Abstract
Thumbnail

It is not only about the looks: safety and feasibility of inter-muscular generator placement of the subcutaneous implantable cardioverter-defibrillator.

Speaker: Doctor J. Kuschyk (Mannheim, DE)

Access
Thumbnail

Prognosis of Patients with Vasospastic Angina Resuscitated from Cardiac Arrest

Speaker: Doctor A. Isshiki (Yokohama, JP)

Access
Abstract
Slides
Thumbnail

Patients managed by non-cardiologists are less likely to be assessed for implantable cardioverter defibrillators

Speaker: Doctor A. Mistry (Leicester, GB)

Access
Abstract
Slides
Thumbnail

Prospective non-invasive evaluation of a novel ECG-based restitution biomarker for prediction of sudden cardiac death risk in ischaemic cardiomyopathy

Speaker: Doctor M. Siddiqui (Nuneaton, GB)

Access
Abstract
Thumbnail

Access the full session

Ventricular arrhythmias and sudden cardiac death (clinical aspects)

Speakers: Miss A. van der Lingen, Doctor M. Testolina, Doctor J. Kuschyk, Doctor A. Isshiki, Doctor A. Mistry...
Access
Thumbnail

About the event

Image

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk